Filgrastim

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Filgrastim and local guidelines before prescribing.

Haematopoietic growth factor

Mechanism

Granulocyte colony-stimulating factor.

Uses

Febrile neutropenia prevention, stem-cell mobilisation, severe chronic neutropenia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Bone pain, splenic rupture (rare), leucocytosis, ARDS.

Interactions

Cytotoxic chemotherapy timing.

Contraindications and cautions

Severe congenital neutropenia caution

Monitoring

FBC

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Do not give within 24 hours of cytotoxic chemotherapy; monitor neutrophils.

More from the textbook: uses, cautions and other points
Where it is discussed in the book